We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Sponsors of COVID-19 treatments may apply for:
- provisional registration through the provisional approval pathway, which provides an expedited pathway for assessment based on available preliminary data
- full registration through the Prescription Medicines Registration Process, if they possess clinical data to confirm the longer-term safety and efficacy of their medicine.
Australia is working internationally to share research and information supporting new COVID-19 treatments. For more information, visit International collaboration.